HRB vs JXN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: JXN is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HRB and JXN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HRB and JXN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

H&R Block prepares individual income tax returns in the United States, Canada and Australia through roughly 9,000 company-owned and franchise offices plus its own DIY software and mobile apps. Revenue comes mostly from fees for assisted returns, with a growing layer of adjacent products: Spruce mobile banking, Refund Transfer, Peace of Mind guarantees, small business services through Block Advisors, and Wave accounting software for the very small business market. The business is unusually concentrated in time. The fiscal year ends June 30, and the January to March quarter carries most of the annual revenue, so the first two fiscal quarters normally report operating losses while the company spends on marketing, seasonal hiring and office readiness ahead of filing season.

Full HRB guide

Jackson Financial (NYSE: JXN) is one of the largest sellers of annuities in the United States, focused on retirement-income products such as variable annuities, registered index-linked annuities (RILAs), and fixed and fixed index annuities distributed through independent advisors and broker-dealers. The company became a standalone public company in 2021 after separating from the UK's Prudential plc, and its core business is collecting premiums, managing the associated market and longevity risk (partly through hedging and reinsurance, including its captive reinsurer Brooke Re), and paying out retirement income over time.

Full JXN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HRB drivers: Price and mix rather than volume; Capital returns that shrink the float.
• JXN drivers: Record annuity sales momentum; Aggressive capital returns.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The structural risk is secular decline in paid assisted tax preparation as DIY software and general-purpose AI assistants make simple returns cheaper to self-file, which would compress volumes even if price per return keeps rising. For JXN, gAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business: the company reported a small GAAP net loss to common shareholders in 2025, a loss of about $435 million in the first quarter of 2026 and a profit of about $644 million in the second, which leaves trailing GAAP net income near only $59 million.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick HRB if you believe its drivers more; JXN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HRB and JXN guides.

HRB. At about $48 on October 16, 2026, HRB traded at a single-digit earnings multiple, well below the broad US market, which reflects a market that treats tax prep volumes as a melting asset rather than a growth business. Fiscal 2026 net income rose about 21% on revenue growth of about 5%, with buybacks and margin doing the rest, and analysts expect fiscal 2027 revenue of about $4.14 billion. The fiscal first quarter (July to September), expected around November 5, normally shows a loss and says little about the coming filing season.

JXN. JXN trades just below book value at a low forward earnings multiple, a pattern common for annuity insurers whose GAAP results swing with markets and hedging. Its trailing GAAP P/E looks extreme (about 145x) only because GAAP net income over the last four quarters was close to zero, while adjusted operating EPS has beaten estimates in three of the last four quarters and analysts expect about $27 for 2026. The valuation and yield largely reflect the company's cash generation and capital-return program, discounted further by doubts about reinsurance accounting raised in September 2026.

Headline figures (approximate, October 2026): HRB shows revenue (fy2026, ended june 30) ~$3.95B (+~5%), net income (fy2026) ~$734M, operating margin (ttm) ~33%, p/e (trailing / forward) ~8.5x / ~7x; JXN shows market cap ~$9.0B, revenue (ttm) ~$6.6B, q2 2026 adjusted operating eps ~$7.30 vs ~$5.76 expected (record), gaap net income (ttm) ~$59M (Q1 loss ~$435M, Q2 profit ~$644M).

HRB and JXN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HRB and JXN exposure against your real portfolio. It is not an investment adviser.